ESPR icon

Esperion Therapeutics

136 hedge funds and large institutions have $352M invested in Esperion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

5.14% more ownership

Funds ownership: 82.66%87.8% (+5.1%)

3% more funds holding

Funds holding: 132136 (+4)

0% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 42

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.4M
Puts
$2.78M
Net Calls
Net Calls Change

Top Buyers

1 +$13.1M
2 +$9.27M
3 +$6.76M
4
WP
Woodline Partners
California
+$5.37M
5
BlackRock
BlackRock
New York
+$3.37M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$49.8K
102
$43K
103
$41K
104
$36K
105
$32K
106
$28K
107
$24K
108
$24K
109
$23K
110
$19K
111
$18K
112
$16K
113
$15K
114
$15K
115
$13K
116
$13K
117
$8K
118
$7K
119
$4K
120
$3K
121
$3K
122
$3K
123
$2K
124
$2K
125
$2K